A real-world, retrospective study to assess the effectiveness and safety of siponimod in Chinese patients with relapsing forms of multiple sclerosis

被引：0
|
作者：
Zhang, Yao [1 ]
Liu, Hongbo [2 ]
Zhou, Ming [3 ]
Li, Zheng [3 ]
Li, Bingbing [4 ]
Cai, Min [3 ]
Shi, Xiaofang [3 ]
Liu, Lyra [3 ]
Lin, Anne [5 ]
Xu, Yan [1 ]
机构：
[1] Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] China Novartis Inst Biomed Res, Shanghai, Peoples R China
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] IQVIA Quintiles IMS, Taipei, Taiwan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1741/928
引用
收藏
页码：1100 / 1100
页数：1
相关论文
共 50 条
  • [1] Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: A real-world retrospective multicenter analysis
    Berkovich, Regina
    Negroski, Donald
    Wynn, Daniel
    Sellers, Daniel
    Bzdek, Kristen G.
    Lublin, Alex L.
    Rawlings, Andreea M.
    Quach, Cuc
    Wells, Danelle P.
    Dumlao, Melanie
    Bora, Adriana
    Ranno, Anthony E.
    Luo, Kevin Lin
    Chavin, Jeffrey
    Hua, Le H.
    Becker, Daniel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [2] Real-world outcomes of siponimod in multiple sclerosis patients
    Tan, Hongmei
    Quan, Chao
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1129 - 1129
  • [3] The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
    Izquierdo, Guillermo
    Damas, Fatima
    Dolores Paramo, Maria
    Luis Ruiz-Pena, Juan
    Navarro, Guillermo
    PLOS ONE, 2017, 12 (04):
  • [4] The real-world safety and effectiveness of ocrelizumab in patients with relapsing multiple sclerosis - a confidence study interim analysis
    Weber, M.
    Buttmann, M.
    Meuth, S.
    Dirks, P.
    Eggebrecht, J.
    Hieke-Schulz, S.
    Leemhuis, J.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 387 - 388
  • [5] Effectiveness and safety of dimethyl fumarate treatment in relapsing multiple sclerosis patients: Real-world evidence
    Alroughani R.
    Ahmed S.F.
    Behbehani R.
    Al-Hashel J.
    Neurology and Therapy, 2017, 6 (2) : 189 - 196
  • [6] Effectiveness and safety of dimethyl fumarate treatment in patients with relapsing multiple sclerosis: A real-world evidence
    Alroughani, Raed
    Ahmed, Samar
    Behbehani, Raed
    Al-hashel, Jasem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP17 - NP17
  • [7] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    S. Batista
    C. C. Nunes
    J. J. Cerqueira
    Ana Martins Silva
    J. Correia de Sá
    J. Ferreira
    M. T. Mendonça
    J. Pinheiro
    V. Salgado
    A. S. Correia
    J. Sequeira
    A. Costa
    L. Sousa
    Neurological Sciences, 2021, 42 : 1995 - 2003
  • [8] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    Batista, S.
    Nunes, C. C.
    Cerqueira, J. J.
    Martins Silva, Ana
    Correia de Sa, J.
    Ferreira, J.
    Mendonca, M. T.
    Pinheiro, J.
    Salgado, V.
    Correia, A. S.
    Sequeira, J.
    Costa, A.
    Sousa, L.
    NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1995 - 2003
  • [9] Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)
    Alroughani, Raed
    AlKawi, Zuhair
    Hassan, Ahmed
    Al Otaibi, Hessa
    Mujtaba, Ahmed
    Al Atat, Rami
    Riachi, Naji
    Akkawi, Nabil
    Koussa, Salam
    Inshasi, Jihad
    Alsaadi, Taoufik
    Ahmed, Samar Farouk
    Al-Aasmi, Abdullah
    Zakaria, Magd
    El Fadally, Haitham
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 203
  • [10] Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: a real-world multicenter analysis
    Berkovich, R.
    Negroski, D.
    Wynn, D.
    Bzdek, K.
    Lublin, A.
    Quach, C.
    Wells, D.
    Bora, A.
    Ranno, A.
    Dumlao, M.
    Luo, K. Lin
    Rawlings, A.
    Chavin, J.
    Hua, L. H.
    Becker, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 54 - 55
12345